Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Huaxing Pharmaceutical is a leading Chinese pharmaceutical company specializing in the development and large-scale production of active pharmaceutical ingredients (APIs) and chemical intermediates. Founded in 1995 and headquartered in Quzhou, Zhejiang, the company has established itself as one of the world's largest suppliers of Gabapentin and Pregabalin. Its manufacturing facilities are fully compliant with international Good Manufacturing Practice (GMP) standards, holding certifications from the US FDA, European EDQM, and Japanese PMDA. Huaxing serves a global clientele, exporting high-quality CNS-related products to over 30 countries. In addition to its core API business, the company provides CDMO services, leveraging its expertise in complex organic synthesis and industrial-scale manufacturing. The firm plays a critical role in the global supply chain for medications treating epilepsy and neuropathic pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huaxing Pharma.